ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,783.44
0.07%
Dow Jones
44,593.65
0.28%
Gold vs US Dollar
2,893.835
-0.17%
Brent Oil
76.115
-0.68%
Bitcoin
96,333.48
0.61%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. XORTX Therapeutics Inc (XRTX)

  7. XORTX Therapeutics Inc (XRTX) News

XORTX Therapeutics (XRTX)

XORTX Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:XRTX
DateTimeSourceHeadlineSymbolCompany
29/01/202512:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
29/01/202512:00GlobeNewswire Inc.XORTX to Present at Microcap ConferenceNASDAQ:XRTXXORTX Therapeutics Inc
22/01/202518:34Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
21/01/202515:24Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
17/01/202522:00GlobeNewswire Inc.XORTX Announces Change of AuditorNASDAQ:XRTXXORTX Therapeutics Inc
06/01/202522:14Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
06/01/202512:00GlobeNewswire Inc.XORTX Adds Late Stage Gout Program to PipelineNASDAQ:XRTXXORTX Therapeutics Inc
19/12/202414:12Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
19/12/202412:00GlobeNewswire Inc.XORTX Strengthens Executive TeamNASDAQ:XRTXXORTX Therapeutics Inc
13/12/202422:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:XRTXXORTX Therapeutics Inc
12/12/202415:19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
12/12/202414:17GlobeNewswire Inc.XORTX Announces Presentation at the Rare and Genetic Disease SummitNASDAQ:XRTXXORTX Therapeutics Inc
26/11/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:XRTXXORTX Therapeutics Inc
22/11/202417:36Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
22/11/202417:29Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
15/11/202422:01Edgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:XRTXXORTX Therapeutics Inc
15/11/202416:23Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
31/10/202414:28Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:XRTXXORTX Therapeutics Inc
24/10/202412:11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
24/10/202411:00GlobeNewswire Inc.XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2024NASDAQ:XRTXXORTX Therapeutics Inc
18/10/202421:22Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
18/10/202421:17Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
18/10/202420:00GlobeNewswire Inc.XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:XRTXXORTX Therapeutics Inc
18/10/202410:09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
18/10/202410:08Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:XRTXXORTX Therapeutics Inc
17/10/202414:43Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
17/10/202412:11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:XRTXXORTX Therapeutics Inc
17/10/202412:00GlobeNewswire Inc.XORTX Announces Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:XRTXXORTX Therapeutics Inc
09/10/202414:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
09/10/202409:00GlobeNewswire Inc.XORTX Initiates Precision Medicine ProgramNASDAQ:XRTXXORTX Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:XRTX

Your Recent History

BIT
UB48HN
Unicredit Bank
BIT
1MPC
Marathon Petro
BIT
1XOM
Exxon Mobil
BIT
P1LLS7
BNP Paribas Issuance
BIT
UC8XVY
Unicredit Bank
BIT
P1JP20
BNP Paribas Issuance
BIT
S29619
Societe Generale Effekten
BIT
SLVRH
SG Issuer
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads